BAKGRUNN (fra kommisjonsforordningen)

(1) Commission Directive 2007/5/EC included folpet as an active substance in Annex I to Council Directive 91/414/EEC. 

(2) Active substances included in Annex I to Directive 91/414/EEC are deemed to have been approved under Regulation (EC) No 1107/2009 and are listed in Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011. 

(3) The approval of the active substance folpet, as set out in Part A of the Annex to Implementing Regulation (EU) No 540/2011 expires on 15 February 2025. 

(4) An application for the renewal of the approval of the active substance folpet was submitted to Austria, the rapporteur Member State, and Italy, the co-rapporteur Member State, in accordance with Article 1 of Commission Implementing Regulation (EU) No 844/2012 within the time period provided for in that Article. 

(5) The applicant submitted the supplementary dossiers required to the rapporteur Member State, the co-rapporteur Member State, the Commission and the European Food Safety Authority (‘the Authority’) in accordance with Article 6 of Implementing Regulation (EU) No 844/2012. The application was found to be complete by the rapporteur Member State. 

(6) The rapporteur Member State prepared a draft renewal assessment report in consultation with the co-rapporteur Member State and submitted it to the Authority and the Commission on 14 March 2018. In its draft renewal assessment report the rapporteur Member State proposed to renew the approval of folpet. 

(7) The Authority also communicated the draft renewal assessment report to the applicant and to the Member States for comments and forwarded the comments received to the Commission. The Authority also made the supplementary summary dossier available to the public. 

(8) On 10 October 2019, the Authority requested additional information from the applicant on the endocrine disrupting properties of folpet pursuant to Article 13(3a), first subparagraph, of Implementing Regulation (EU) No 844/2012. The applicant submitted information for the Authority to assess whether the scientific criteria for the determination of endocrine disrupting properties set out in points 3.6.5 and 3.8.2 of Annex II to Regulation (EC) No 1107/2009, as introduced by Commission Regulation (EU) 2018/605, were met. 

(9) In May 2022, the rapporteur Member State made an updated draft renewal assesment report available to the Authority, the Member States and the Commission. In its updated draft renewal assessment report, the rapporteur Member State considered the additional information regarding the criteria to identify endocrine disrupting properties and proposed to renew the approval of folpet. 

(10) On 12 July 2023, the Authority communicated to the Commission its conclusion on whether folpet can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009. 

(11) The Commission presented a renewal report on 20 March 2024 and a draft of this Regulation on 22 May 2024 to the Standing Committee on Plants, Animals, Food and Feed. 

(12) The Commission invited the applicant to submit its comments on the conclusion of the Authority and, in accordance with Article 14(1), third subparagraph, of Implementing Regulation (EU) No 844/2012, on the renewal report. The applicant submitted its comments, which have been carefully examined and taken into due consideration. 

(13) It has been established with respect to one or more representative uses of at least one plant protection product containing the active substance folpet that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied. 

(14) Although the risk assessment for the renewal of the approval of the active substance folpet is based on a limited number of representative uses, this does not restrict the uses for which plant protection products containing folpet may be authorised. It is therefore appropriate not to maintain the restriction to use folpet as a fungicide. 

(15) It is therefore appropriate to renew the approval of folpet 

(16) It is, however, necessary to provide for certain conditions in accordance with Article 14(1) of Regulation (EC) No 1107/2009 in conjunction with Article 6 thereof and in the light of current scientific and technical knowledge and the outcome of the risk assessment. Considering the high acute risk to fish and aquatic invertebrates identified in the risk assessment, it is appropriate to require minimum risk mitigation measures to protect those aquatic organisms from exposure to folpet unless the outcome of the risk assessment undertaken for specific plant protection product uses indicates that such risk mitigation measures are not needed or can be lowered. Furthermore, to finalise the consumer exposure, it is in particular appropriate to request confirmatory information to determine the levels of phthalic acid deriving from the use of folpet taking into account the background levels of phthalic acid present in wheat and barley during residue field trials for the uses listed in Appendix II of the renewal report only. 

(17) Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly. 

(18) Commission Implementing Regulation (EU) 2023/918 extended the approval period of folpet to 15 February 2025 in order to allow the renewal process to be completed before the expiry of the approval period of that active substance. However, given that a decision on the renewal has been taken ahead of that extended expiry date, this Regulation should start to apply earlier than that date. 

(19) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,